Viewing Study NCT02377466


Ignite Creation Date: 2025-12-24 @ 4:16 PM
Ignite Modification Date: 2026-01-05 @ 6:01 PM
Study NCT ID: NCT02377466
Status: TERMINATED
Last Update Posted: 2020-07-28
First Post: 2015-02-26
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Phase III Efficacy and Safety Study of Intravenous Retosiban Versus Placebo for Women in Spontaneous Preterm Labor
Sponsor: GlaxoSmithKline
Organization: